Blog

Filippo Gallina: PD-L1 testing in the context of neoadjuvant chemo-immunotherapy

Photo from Filippo Gallina/X

Aug 3, 2024, 08:51

Filippo Gallina: PD-L1 testing in the context of neoadjuvant chemo-immunotherapy

Filippo Gallina, Research Fellow at McGill University Health, shared his recent article on X:

“Happy to share those considerations published on Lung Cancer Journal about PD-L1 testing in the context of neoadjuvant chemo-immunotherapy. Thanks to all the co-authors!”

Title: Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC

Authors: Filippo Tommaso Gallina, Vittoria Balzano, Nicla Porciello, Riccardo Tajè, Daniele Forcella, Enrico Melis, Fabiana Letizia Cecere, Francesca Fusco, Simonetta Buglioni, Paolo Visca, Paola Nisticò, Federico Cappuzzo, Jonathan Spicer

Source: Filippo Gallina/X

cancer chemo-immunotherapy Fabiana Cecere Federico Cappuzzo Filippo Tommaso Gallina Jonathan Spicer Lung Cancer Journal Nicla Porciello OncoDaily Oncology PD-L1 testing Vittoria Balzano

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage